يعرض 1 - 10 نتائج من 16 نتيجة بحث عن '"Louisa R Hoes"', وقت الاستعلام: 1.02s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

    المؤلفون: Birgit S. Geurts, Thomas W. Battaglia, J. Maxime van Berge Henegouwen, Laurien J. Zeverijn, Gijs F. de Wit, Louisa R. Hoes, Hanneke van der Wijngaart, Vincent van der Noort, Paul Roepman, Wendy W. J. de Leng, Anne M. L. Jansen, Frans L. Opdam, Maja J. A. de Jonge, Geert A. Cirkel, Mariette Labots, Ann Hoeben, Emile D. Kerver, Adriaan D. Bins, Frans G.L. Erdkamp, Johan M. van Rooijen, Danny Houtsma, Mathijs P. Hendriks, Jan-Willem B. de Groot, Henk M. W. Verheul, Hans Gelderblom, Emile E. Voest

    المصدر: BMC Cancer, Vol 23, Iss 1, Pp 1-14 (2023)

    مصطلحات موضوعية: Durvalumab, Immunotherapy, Microsatellite instability, Mismatch repair deficiency, Precision medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/1471-2407Test

    الوصول الحر: https://doaj.org/article/0e6af27c660548eab8d0d86d81fe251dTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.

    المؤلفون: Joris van de Haar, Xuhui Ma, Salo N Ooft, Pim W van der Helm, Louisa R Hoes, Sara Mainardi, David J Pinato, Kristi Sun, Lisa Salvatore, Giampaolo Tortora, Ina Valeria Zurlo, Silvana Leo, Riccardo Giampieri, Rossana Berardi, Fabio Gelsomino, Valeria Merz, Federica Mazzuca, Lorenzo Antonuzzo, Gerardo Rosati, Chara Stavraka, Paul Ross, Maria Grazia Rodriquenz, Michele Pavarana, Carlo Messina, Timothy Iveson, Federica Zoratto, Anne Thomas, Elisabetta Fenocchio, Margherita Ratti, Ilaria Depetris, Massimiliano Cergnul, Cristina Morelli, Michela Libertini, Alessandro Parisi, Michele De Tursi, Nicoletta Zanaletti, Ornella Garrone, Janet Graham, Raffaella Longarini, Stefania Maria Gobba, Angelica Petrillo, Emiliano Tamburini, Nicla La Verde, Fausto Petrelli, Vincenzo Ricci, Lodewyk FA Wessels, Michele Ghidini, Alessio Cortellini, Emile E Voest, Nicola Valeri

    مصطلحات موضوعية: Uncategorized, Uncategorised value

    العلاقة: 2381/22285612.v1; https://figshare.com/articles/journal_contribution/Codon-specific_KRAS_mutations_predict_survival_benefit_of_trifluridine_tipiracil_in_metastatic_colorectal_cancer_/22285612Test

    الإتاحة: https://figshare.com/articles/journal_contribution/Codon-specific_KRAS_mutations_predict_survival_benefit_of_trifluridine_tipiracil_in_metastatic_colorectal_cancer_/22285612Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)

    المؤلفون: Kris G. Samsom, Linda J. W. Bosch, Luuk J. Schipper, Paul Roepman, Ewart de Bruijn, Louisa R. Hoes, Immy Riethorst, Lieke Schoenmaker, Lizet E. van der Kolk, Valesca P. Retèl, Geert W. J. Frederix, Tineke E. Buffart, Jacobus J. M. van der Hoeven, Emile E. Voest, Edwin Cuppen, Kim Monkhorst, Gerrit A. Meijer

    المصدر: BMC Medical Genomics, Vol 13, Iss 1, Pp 1-7 (2020)

    مصطلحات موضوعية: Cancer, Diagnostics, Whole genome sequencing, Biomarker, Personalized medicine, Internal medicine, RC31-1245, Genetics, QH426-470

    وصف الملف: electronic resource

    العلاقة: http://link.springer.com/article/10.1186/s12920-020-00814-wTest; https://doaj.org/toc/1755-8794Test

    الوصول الحر: https://doaj.org/article/b893dbefe1164ff4809d89051f9ba87dTest

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  4. 4
    Supplementary Figure 1 from Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types

    المؤلفون: Henk M.W. Verheul, Emile E. Voest, Hans Gelderblom, Paul Hamberg, Ann Hoeben, Derk Jan A. de Groot, Mariette Labots, Debbie G.J. Robbrecht, Niven Mehra, Anne M.L. Jansen, Wendy W.J. de Leng, Erik van Werkhoven, Paul Roepman, Laurien J. Zeverijn, Daphne L. van der Velden, J. Maxime van Berge Henegouwen, Louisa R. Hoes, Hanneke van der Wijngaart

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65097be0eb5d177688ddeb4db508010bTest
    https://doi.org/10.1158/1078-0432.22481003.v1Test


    أضف إلى المفضلة
  5. 5
    Supplementary Figure from Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

    المؤلفون: Emile E. Voest, Henk M.W. Verheul, Hans Gelderblom, Edwin Cuppen, Martijn P. Lolkema, Hans Morreau, Ann Hoeben, Mariette Labots, Carla M.L. van Herpen, Winette T.A. van der Graaf, Egbert F. Smit, Mathijs P. Hendriks, Laurens V. Beerepoot, Frans Erdkamp, Derk Jan de Groot, Emile D. Kerver, Jan Willem B. de Groot, Eelke H. Gort, Alwin D.R. Huitema, Vincent van der Noort, Erik van Werkhoven, Anne M.L. Jansen, Wendy J. de Leng, Paul Roepman, Joris van de Haar, Daphne L. van der Velden, Laurien J. Zeverijn, Hanneke van der Wijngaart, Jade M. van Berge Henegouwen, Louisa R. Hoes

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142be478802724901bf5b4aba218bf7cTest
    https://doi.org/10.1158/1078-0432.22487285.v1Test


    أضف إلى المفضلة
  6. 6
    Data from Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

    المؤلفون: Emile E. Voest, Henk M.W. Verheul, Hans Gelderblom, Edwin Cuppen, Martijn P. Lolkema, Hans Morreau, Ann Hoeben, Mariette Labots, Carla M.L. van Herpen, Winette T.A. van der Graaf, Egbert F. Smit, Mathijs P. Hendriks, Laurens V. Beerepoot, Frans Erdkamp, Derk Jan de Groot, Emile D. Kerver, Jan Willem B. de Groot, Eelke H. Gort, Alwin D.R. Huitema, Vincent van der Noort, Erik van Werkhoven, Anne M.L. Jansen, Wendy J. de Leng, Paul Roepman, Joris van de Haar, Daphne L. van der Velden, Laurien J. Zeverijn, Hanneke van der Wijngaart, Jade M. van Berge Henegouwen, Louisa R. Hoes

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20708b4724c2bca311186b13b326a529Test
    https://doi.org/10.1158/1078-0432.c.6532484Test


    أضف إلى المفضلة
  7. 7
    Supplementary Table from Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

    المؤلفون: Emile E. Voest, Henk M.W. Verheul, Hans Gelderblom, Edwin Cuppen, Martijn P. Lolkema, Hans Morreau, Ann Hoeben, Mariette Labots, Carla M.L. van Herpen, Winette T.A. van der Graaf, Egbert F. Smit, Mathijs P. Hendriks, Laurens V. Beerepoot, Frans Erdkamp, Derk Jan de Groot, Emile D. Kerver, Jan Willem B. de Groot, Eelke H. Gort, Alwin D.R. Huitema, Vincent van der Noort, Erik van Werkhoven, Anne M.L. Jansen, Wendy J. de Leng, Paul Roepman, Joris van de Haar, Daphne L. van der Velden, Laurien J. Zeverijn, Hanneke van der Wijngaart, Jade M. van Berge Henegouwen, Louisa R. Hoes

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::147164e4fc1bf7625772c998491fda4dTest
    https://doi.org/10.1158/1078-0432.22487279Test


    أضف إلى المفضلة
  8. 8
    Supplementary Table 1 from Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types

    المؤلفون: Henk M.W. Verheul, Emile E. Voest, Hans Gelderblom, Paul Hamberg, Ann Hoeben, Derk Jan A. de Groot, Mariette Labots, Debbie G.J. Robbrecht, Niven Mehra, Anne M.L. Jansen, Wendy W.J. de Leng, Erik van Werkhoven, Paul Roepman, Laurien J. Zeverijn, Daphne L. van der Velden, J. Maxime van Berge Henegouwen, Louisa R. Hoes, Hanneke van der Wijngaart

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::682d1fd9a2218e77908d809143d1cd4aTest
    https://doi.org/10.1158/1078-0432.22480997Test


    أضف إلى المفضلة
  9. 9
    Supplementary Legend from Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types

    المؤلفون: Henk M.W. Verheul, Emile E. Voest, Hans Gelderblom, Paul Hamberg, Ann Hoeben, Derk Jan A. de Groot, Mariette Labots, Debbie G.J. Robbrecht, Niven Mehra, Anne M.L. Jansen, Wendy W.J. de Leng, Erik van Werkhoven, Paul Roepman, Laurien J. Zeverijn, Daphne L. van der Velden, J. Maxime van Berge Henegouwen, Louisa R. Hoes, Hanneke van der Wijngaart

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c673b41d7e1809c121882b30b75a551fTest
    https://doi.org/10.1158/1078-0432.22481000Test


    أضف إلى المفضلة
  10. 10
    Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

    المؤلفون: Louisa R. Hoes, Jade M. van Berge Henegouwen, Hanneke van der Wijngaart, Laurien J. Zeverijn, Daphne L. van der Velden, Joris van de Haar, Paul Roepman, Wendy J. de Leng, Anne M.L. Jansen, Erik van Werkhoven, Vincent van der Noort, Alwin D.R. Huitema, Eelke H. Gort, Jan Willem B. de Groot, Emile D. Kerver, Derk Jan de Groot, Frans Erdkamp, Laurens V. Beerepoot, Mathijs P. Hendriks, Egbert F. Smit, Winette T.A. van der Graaf, Carla M.L. van Herpen, Mariette Labots, Ann Hoeben, Hans Morreau, Martijn P. Lolkema, Edwin Cuppen, Hans Gelderblom, Henk M.W. Verheul, Emile E. Voest

    المساهمون: Medical Oncology, Internal medicine, CCA - Cancer Treatment and quality of life, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Radiology and Nuclear Medicine, Graduate School, APH - Methodology, APH - Personalized Medicine, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Clinical Cancer Research, 28(7), 1402-1411. American Association for Cancer Research Inc.
    Clinical Cancer Research, 28(7), 1402-1411. AMER ASSOC CANCER RESEARCH
    Clinical Cancer Research, 28, 1402-1411
    Hoes, L R, van Berge Henegouwen, J M, van der Wijngaart, H, Zeverijn, L J, van der Velden, D L, van de Haar, J, Roepman, P, de Leng, W J, Jansen, A M L, van Werkhoven, E, van der Noort, V, Huitema, A D R, Gort, E H, de Groot, J W B, Kerver, E D, de Groot, D J, Erdkamp, F, Beerepoot, L V, Hendriks, M P, Smit, E F, van der Graaf, W T A, van Herpen, C M L, Labots, M, Hoeben, A, Morreau, H, Lolkema, M P, Cuppen, E, Gelderblom, H, Verheul, H M W & Voest, E E 2022, ' Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment ', Clinical Cancer Research, vol. 28, no. 7, pp. 1402-1411 . https://doi.org/10.1158/1078-0432.CCR-21-3752Test
    Clinical cancer research, 28(7), 1402-1411. American Association for Cancer Research Inc.
    Clinical Cancer Research, 28, 7, pp. 1402-1411

    مصطلحات موضوعية: Proto-Oncogene Proteins B-raf, Cancer Research, Genomics, THERAPY, TUMORS, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], MODEL, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], All institutes and research themes of the Radboud University Medical Center, Oncology, SDG 3 - Good Health and Well-being, Neoplasms, Humans, Molecular Targeted Therapy, Precision Medicine, BURDEN, Rare cancers Radboud Institute for Health Sciences [Radboudumc 9]

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d10b5fcc9b5bf485e35845851e46056dTest
    https://doi.org/10.1158/1078-0432.ccr-21-3752Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث